Language selection

Search

Patent 1330951 Summary

Third-party information liability

Some of the information on this Web page has been provided by external sources. The Government of Canada is not responsible for the accuracy, reliability or currency of the information supplied by external sources. Users wishing to rely upon this information should consult directly with the source of the information. Content provided by external sources is not subject to official languages, privacy and accessibility requirements.

Claims and Abstract availability

Any discrepancies in the text and image of the Claims and Abstract are due to differing posting times. Text of the Claims and Abstract are posted:

  • At the time the application is open to public inspection;
  • At the time of issue of the patent (grant).
(12) Patent: (11) CA 1330951
(21) Application Number: 570656
(54) English Title: SYNTHETIC POLYMER FOR ENDOCAPSULAR LENS REPLACEMENT
(54) French Title: POLYMERE SYNTHETIQUE POUR LE REMPLACEMENT DU CRISTALLIN ENDOCAPSULAIRE
Status: Deemed expired
Bibliographic Data
(52) Canadian Patent Classification (CPC):
  • 3/112
  • 167/328
(51) International Patent Classification (IPC):
  • A61L 27/00 (2006.01)
  • A61F 2/16 (2006.01)
  • A61F 9/00 (2006.01)
  • A61L 27/14 (2006.01)
(72) Inventors :
  • PINE, STANLEY H. (United States of America)
  • COOTS, ROBERT J. (United States of America)
  • GRUBBS, ROBERT H. (United States of America)
(73) Owners :
  • CALIFORNIA INSTITUTE OF TECHNOLOGY (United States of America)
(71) Applicants :
(74) Agent: BORDEN LADNER GERVAIS LLP
(74) Associate agent:
(45) Issued: 1994-07-26
(22) Filed Date: 1988-06-28
Availability of licence: N/A
(25) Language of filing: English

Patent Cooperation Treaty (PCT): No

(30) Application Priority Data:
Application No. Country/Territory Date
07/070,060 United States of America 1987-07-06

Abstracts

English Abstract




SYNTHETIC POLYMER FOR ENDOCAPSULAR LENS REPLACEMENT

ABSTRACT OF THE DISCLOSURE
A synthetic polymer (24) is provided for endocapsular
lens (18) replacement in an eye (10). The polymer, which
is injected into the lens capsule (16) after removal of
the lens, comprises an oxygen-stabilized photosensitive
prepolymer. An example of such a prepolymer comprises
polyether with urethane linkages with one or both ends
capped with a functional group containing at least one
double bond, such as an acrylate, a methacrylate, or a
styrene.

The polymerization reaction is initiated with a pho-
toinitiator such as dimethoxyphenylacetophenone and is
quenched in the presence of oxygen. Contrary to the prior
art polymers, the time of curing is on the order of only a
minute or so. The viscosity and thickness of the polymer
formed may be tailored to achieve a desired index of re-
fraction of between about 1.3. and 1.6.


Claims

Note: Claims are shown in the official language in which they were submitted.


THE EMBODIMENTS OF THE INVENTION IN WHICH AN EXCLUSIVE PROPERTY
OR PRIVILEGE IS CLAIMED ARE DEFINED AS FOLLOWS:

1. Use of a cured synthetic polymer as the
replacement for a lens which has been removed from a lens
capsule of an eye, said polymer being the product of in vivo
exposure to light and curing within several minutes of a
deoxygenated polymer composition comprising a photo-sensitive
prepolymer and a photoinitiator provided within said lens
capsule.
2. Use of a cured synthetic polymer as the
replacement for a lens which has been removed from a lens
capsule of an eye, said polymer being the product of in vivo
exposure to light and during within several minutes at ambient
temperature of a deoxygenated polymer composition comprising a
photo-sensitive prepolymer and a photoinitiator provided within
said lens capsule.
3. Use of a cured synthetic polymer as claimed in
claim 1 or 2 wherein said photoinitiator comprises an
acetophenone derivative.
4. Use of a cured synthetic polymer as claimed in
claim 3 wherein said photoinitiator comprises
dimethoxyphenylacetophenone.
5. Use of a cured synthetic polymer as claimed in
claim 1 or 2 wherein said photoinitiator is present in an amount
ranging from about 0.25 to 2 wt%.
6. Use of a cured synthetic polymer as claimed in
claim 1 or 2 wherein said light is visible-to-near-UV radiation.
7. Use of a cured synthetic polymer as claimed in
claim 1 or 2 wherein said prepolymer has been stabilized against
polymerization with oxygen.
8. Use of a cured synthetic polymer as claimed in
claim 1 or 2 wherein said prepolymer is substantially linear,
with at least one end capped with a functional group having at
least one olefinic bond.

9. Use of a cured synthetic polymer as claimed in
claim 8 wherein said functional group is one selected from the
group consisting of acrylates, methacrylates, and styrenes.
10. Use of a cured synthetic polymer as claimed in
claim 9 wherein said functional group comprises a methacrylate.
11. Use of a cured synthetic polymer as claimed in
claim 8 wherein said prepolymer comprises a composition selected
from the group consisting of urethanes, polypropylene glycols,
polypropylene glycols with polyethylene glycol units,
polybutylene glycols with polyethylene glycol units, and
silicones.
12. Use of a cured synthetic polymer as the
replacement for a lens which has been removed from a lens
capsule of an eye, said polymer being the product of in vivo
exposure to light and curing within about five minutes of a
deoxygenated polymer composition comprising a photo-sensitive
prepolymer and a photoinitiator comprising an acetophenone
provided within said lens capsule, said prepolymer comprising a
polyether having both ends capped with an acrylate group and
stabilized against polymerization with oxygen.
13. Use of a cured synthetic polymer as the
replacement for a lens which has been removed from a lens
capsule of an eye, said polymer being the product of in vivo
exposure to light and curing at ambient temperature within about
five minutes of a deoxygenated polymer composition comprising a
photo-sensitive prepolymer and a photoinitiator comprising an
acetophenone provided within said lens capsule, said prepolymer
comprising a polyether having both ends capped with an acrylate
group and having been stabilized against polymerization with
oxygen.
14. Use of a cured synthetic polymer as claimed in
claim 12 or 13 wherein said photoinitiator comprises
dimethoxyphenylacetophenone.
15. Use of a cured synthetic polymer as defined in
claim 14 wherein said photoinitiator is present in an amount
ranging from about 0.25 to 2 wt%.
11

16. Use of a cured synthetic polymer as defined in
claim 14 wherein said light is visible-to-near-UV radiation.
17. Use of a cured synthetic polymer as defined in
claim 12 or 13 wherein said acrylate group comprises a
methacrylate.
18. Use of a deoxygenated polymer composition for
forming a polymeric endocapsular lens replacement in the lens
capsule of an eye from which the lens has been removed by
providing said composition in the lens capsule and forming the
replacement lens by in vivo exposure of said composition to
light and curing said composition within several minutes, said
composition comprising a photo-sensitive prepolymer and a
photoinitiator.
19. Use of a deoxygenated polymer composition for
forming a polymeric endocapsular lens replacement in the lens
capsule of an eye from which the lens has been removed by
providing said composition in the lens capsule and forming the
replacement lens by in vivo exposure of said composition to
light and curing said composition within several minutes at
ambient temperature, said composition comprising a
photo-sensitive prepolymer and a photoinitiator.
20. Use of a deoxygenated polymer composition as
claimed in claim 18 or 19 wherein said photoinitiator comprises
an acetophenone derivative.
21. Use of a deoxygenated polymer composition as
claimed in claim 20 wherein said photoinitiator comprises
dimethoxyphenylacetophenone.
22. Use of a deoxygenated polymer composition as
claimed in claim 18 or 19 wherein said photoinitiator is present
in an amount ranging from about 0.25 to 2 wt%.
23. Use of a deoxygenated polymer composition as
claimed in claim 18 or 19 wherein said light is
visible-to-near-UV radiation.
24. Use of a deoxygenated polymer composition as
claimed in claim 18 or 19 wherein said prepolymer has been
stabilized against polymerization with oxygen.
12

25. Use of a deoxygenated polymer composition as
claimed in claim 18 or 19 wherein said prepolymer is
substantially linear, with at least one end capped with a
functional group having at least one olefinic bond.
26. Use of a deoxygenated polymer composition as
claimed in claim 25 wherein said functional group 18 one
selected from the group consisting of acrylates, methacrylates,
and styrenes.
27. Use of a deoxygenated polymer composition as
claimed in claim 26 wherein said functional group comprises a
methacrylate.
28. Use of a deoxygenated polymer composition as
claimed in claim 25 wherein said prepolymer comprises a
composition selected from the group consisting of urethanes,
polypropylene glycols, polypropylene glycols with polyethylene
glycol units, polybutylene glycols with polyethylene glycol
units, and silicones.
29. Use of a deoxygenated polymer composition for
forming a polymeric endocapsular lens replacement in the lens
capsule of an eye from which the lens has been removed by
providing said composition in the lens capsule and forming the
replacement lens by in vivo exposure of said composition to
light and curing said composition within about five minutes,
said composition comprising a photo-sensitive prepolymer and a
photoinitiator comprising an acetophenone, said prepolymer
comprising a polyether having both ends capped with an acrylate
group and stabilized against polymerization with oxygen.
30. Use of a deoxygenated polymer composition for
forming a polymeric endocapsular lens replacement in the lens
capsule of an eye from which the lens has been removed by
providing said composition in the lens capsule and forming the
replacement lens by in vivo exposure of said composition to
light and curing said composition within about five minutes at
ambient temperature, said composition comprising a
photo-sensitive prepolymer and a photoinitiator comprising an
acetophenone, said prepolymer comprising a polyether having both
13

ends capped with an acrylate group and having been stabilized
against polymerization with oxygen.
31. Use of a deoxygenated polymer composition as
claimed in claim 29 or 30 wherein said photoinitiator comprises
dimethoxyphenylacetophenone.
32. Use of a deoxygenated polymer composition as
claimed in claim 31 wherein said photoinitiator is present in an
amount ranging from about 0.25 to 2 wt%.
33. Use of a deoxygenated polymer composition as
claimed in claim 31 wherein said light is visible-to-near-UV
radiation.
34. Use of a deoxygenated polymer composition as
claimed in claim 29 or 30 wherein said acrylate group comprises
a methacrylate.

14

Description

Note: Descriptions are shown in the official language in which they were submitted.


~ `:` 1 1 330951

.... .
,, .~ ,.~ ,. . ~,
PAT~NT ;~::
CIT-~88~

SYNT~TIC PO~YME~ FOR ~NDO~APSUI.AR ~NS RE~AC~M~NT ~-.
:- - ;:.: -: ..

T~CNNICAI. FIIU.D

The present lnvention relates to treatment~ ol~ de~ect~
;~ ~ ln the eye, ~nd, a~ore partlcularly, to the roplacement of
di~eased or otherwlse ~efoctlve eye len~e~
, ................................................................................. ......... .
- ~,,
ACKGROUND ART

Sur~ery on the ~ye l~:b~co~ing Dore co~monplace und
10 sophistlcated ~B new technlgues and devlc~ are :;~eveloped .
to :co~bat i~palred~si~ht or even blin~n~s. ;~One ~uch
; field of ~urgery i8 the:replace~ent of the lens ln th~ eye
whlch~can be necessitated~,:for:exa~ple, by ca~aract devel~
op~ent, wh~oh:opaclfl~s the lens. :~
15: ~ Procedures have be~n d~veloped~for removal of th~
len~ Early procedures have~1nvolvèd:th~ re~oval of the
ens~:and~l-ns~cap-ule (transpar-nt~ ~bran- onc-psulatlng : ~.
the lens) by ~eans of forceps~or suction.~ More recently,
less~ trau~atlc aeans have been devoloped: ouch ~ean~:;ln~
20~ volve ~partloul~tlng ~the l-n-, an exa~pl~ ~of ~hlch ~ 18
: called onlcatlon, ~hlch lnvolve~ ultr~oonlc di~inte~ra~
tion of the len~ by.appllcatlon of hl~h frQquency vlbra- ~a~
tlQn8 thereto. The lens fra~ent~ ar~ then r~oved ~y
pir~tion. :~
25:~ ~ ~Replac~nt of the l~ns to:~vold r~quirln~ the pa~
~:;tlent to ~ear ~pectaclc~ ~ith ~a~lv-~ -nRe3 has ~been '~ ''.'t~
inve~tl~ated. So~e 801UtloD~ hav~ lnoludo~ in~actln~ a



,. ~ 2 1330~51

vi~couo liquld or a sillcone into the ~acant l~ns cap~ule.
Implantation of lntraocular lenses has also been done, but
the l~plant i8 rl~ld and not ~ocu~able and 18 oaslly dls~
lod~ed by shock or vibratlon.

More recently, G. M. Wr1~ht ~nd T. D. Talcott ln U.S.
Patent~ 3~,943; 4,642,~42; and 4,G08,050 have dlsclosed
ln~ectlon by n~edle of a poly~erlc lomposition into the
lens capsule. The poly~eric composl~ion comprl~es a slli~
cone prepolymer, a croos-llnker and a platlnum-based cata-
10 lyst. The composltlon cures ln thle l~n8 capoule to an -:~:
optically clear, ~el-ll~e ~at~rial whlch may accommodate,
or focus, through action of the eye lans mu3cle~.
However, a proble~ with the polymeric composltion
disclosed 18 that a ~eparate h~ating step is required to ;~
15 permit removal of the needle fro~ the eye to lnltiate :~:
polymerlzatlon at the ln~cctlon slte and thus prevent 108s
of polymer therefrom. Further, the tlme of lnltlal cross- :
linking i8 on the order o~ ~everal hour8, whlch lnvolves
lengthy immobillzatlon of the eye to per~lt co~plete cur-
ing.
Thus, what i8 reqUirQd i8 a poly~eric compofiitlon
providlng the advantayes of the prior art while avoidlng
~ost, lf not all, the problem~ assoclated wlth the prlor ~
art approache~. :
:
DISCLOSURE OF INVENTION

In accordance wlth the lnventlon, a ~ynthetlc polymer
is provided for endocapsular lens replac~3ent. The poly-
ner, which is ln~ect~d into the lens capsule after rc~ovalof the l-n~s, co~prlses an oxy~en-stabill~od photocon~ltlve
prepolymer. An 2xa~ple of ~uch a prepolymer comprises a
polyether with urethane llnkages wlth one or both ~nds
capped with a ~unctlonal yroup containin~ at l~a~t one
' ~


,., ,, i ~

r~ ~

" -~ 1 3 3 0 q 5 1 . '~
- 3 -

double bond, such as an acrylate, methacrylate, or a sty~
rene.
The polymerization reaction is initiated by light
using a photoinitiator such as dimethoxyphenylacetophen~
one and other aryl ketones and is ~uenched in the
presence of oxygen. Contrary to the prior art polymers,
the time of curing is on the order of only a minute or
so. The viscosity and thickness of the polymer formed
may be tailored to achieve a desired index of refraction.
In accordance with a first aspect of the present
invention there is provided a method of endocapsular
lens replacement by forming a synthetic polymer in the
lens capsule of an eye after removal of the lens
comprising: (a~ injecting a polymer composition
comprising a photo-sensitive prepolymer and a
photoinitiator into the lens capsule in the absence of
oxygen; (b) exposing the composition to light to form
the synthetic polymer; and (c) curing the polymer within
several minutes.
', ~: ~',.'

BRIEF DESCRIPTION OF THE DRAWINGS ~ ;

Figs. 1-5 are diagrammatic views of a portion of
an eye, showing the procedure of lens removal, followed
by injection of the polymer used in the method of the
invention.
",. : .: ~'~

.:. ~..:
. ~ ,..



,' ~

-: I 33095 1 ~
- 3a ~

BEST_MODES FOR CARRYING OUT THE INVENTION

Referring now to the drawings, wherein like
numerals designate like elements throughout, a portion
of an eye 10 is shown, with a probe 12 inserted through
the cornea 14 and the lens capsule 16 into the lens 18.
As shown in FIG. 1, the probe, which advantageously
comprises means for emitting high frequency vibrations, ~:~
has caused ultrasonic disintegration of the lens 18 by a
10 process known as sonication. In FIG. 2, the probe 12, :~
which also includes aspiration means 12', has begun . :~
removal of the denatured protein of the lens, or lens
fragments, 18. In FIG. 3, the process is complete,
leaving behind the empty lens capsule 16. The
15 particular method of disintegrating the lens and e
removing it is immaterial to the practice of the ~ ~:
invention, and thus forms no part of this invention~ :-
n FIG. 4, a needle 20 is inserted into the same
incisions 22a and 22b by the probe 12 and is used to inject a


: ,..




.



~, ~
'~ '' , .
: ,

1 poly~er co~posltlon 2~ lnto the lonl c~p~ull 16. Th~
polymer 18 d~oxy~enated prlor to inJectlon.
Th~ needle 20 18 ~radually wlthdr~wn a~ the polymer


flll~ the capsule 16 and the lncislon 22a throu~h the


cornea 14 18 ~ur~lcally clo~ed. Since the polymer cures
to lt~ S~nal ~tatQ wlthin ~ ~attor of ~lnutos u~in~ ht,
no heatlng ot~p 18 r~qulrQd to cure the poly~cr around the
lnci~lon 22b ln the l~ns capBule 16 to per~lt removal of
the needle 20. The co~pletely filled lens c~p~ule 16 18
depicted ln FIG. 5.
The poly~er composltlon 2~ 1B lnJected lnto the lens
capsule 16 throu~h 31it 22b, ~h~ch 18 typlcally no larger
than 3 ~, and i8 ~ntended to cro~s-link rapldly ~o that
the compositlon, which la lnJectod in a llquid ctate, wlll
not squlrt out the sllt when th~ needle 20 1B with~r~wn.
The poly~er compo3it~0n us~d ln the practlc~ of the
invention co~prises (a) a prepoly~er and (b) a photoinitl-
ator. The prepoly~er 18 preferably one that 18 ~ubstan-

tially llnear, with one, znd preferably both, onds capped


with a functional group h2vin~ at least one olefinlc bond.~amples of ~uch ~unctional yroups lnclude acrylates,
~ethacrylates, ~nd styren-s.
It 15 pre~erred that both ~nds be capped, ln order to
for~ a ~ore ho~ogeneous poly~er. The pre~ence of ~he
double bond p~rmlts olofinlc-type cro~s-llnkln~.
Exa~ples Or ~ultable prspoly~-rs include polypropyl~
~ne ~lycols, polypropylene ~lyC018 wlth polyethylene ~ly-
col unlts, polybutylene ~lycols wlth pcly~thylene ~lycol
unlts, urethanes, and ~llloones such as dl~ethyl sllicone
and ethyl slllcone. The ~olecular wel~ht o~ the prepoly~
~er ~dvantay~ously ranges from about 2,000 to 8,000, al-
thou~h lower or hl~h~r ~olecular wei~ht ~aterlal ~y b~
e~ployed
The photoinitlator co~prises a co~po~ltlon ~hlch
inltlatos poly~erlzation o~ ol~flnlc ~nd ~roups ~n the




..

~``` 1 33()~5i
1 vi~lblo-to-near- W r~on. ~xa~plas oS such photolnltla-
tors, partlcularly sultcd Por c~usin~' cro~s-llnklng of
acrylat~ ~roups, lnclude ac~tophenon2 d~rlvatlvo~, ~uch ~8
~l~ethoxyphenylac~tophenone.
The procodure ~or for~ation ~ld re~oval Or l~n3 ~ra~-
~ents 18 lnvolv~ tho u~e Or a alcro~copa and a l~mp ror
lllumlnatlon of the eye. ~hen lnJectlng the poly~er co~-
posltlon 2~ lnto the lon~ capsulc 16, th~ cros~-llnklng
procedure ~ay be perfor~ed u~ln~ the same la~p ~mployed ln
con~unctlon wlth tho ~lcroscope ~ d by the ~ur~on to
r~move the lens fr~y~ents 18. Thl~ lamp i8 0~ th~ appro-
prlatc wavelen~th and i~ of ~uffic:lent ~nt~nsity to actl-
vate the photolnitiator and b~ln the proces~ of cross-
llnking. The concentratlon of photolnitiator ~8 nor~ally
about 0.25 to 2 wt%.
The time ~or reaction 1~ ordin~rlly 1~8~ than about
five ~lnutes. The obs~rvable physlcal properties do not
seem to chan~e aftcr the ~lrst ~everal ~lnu~ of cross-
l$nklng.
The photoinltiator i8 quenched by the presence Or
oxygen, ~nd ~ccordin~ly, the operation ~ay be done by
contlnuously ~lushln~ the eye wlth an lnert gas, such as
nltrogen or arqon, or wlth saline untll th~ reaction i~
~ubstanti~lly co~plete.
The prepoly~er 18 ~tabil~z~d wlth oxyg~ durln~ stor~
in~ and sample pr~par~tion and do~a~ed in the dark before
ln~ectlon, ~uch ~a wlth a vacuum pU~p, ~nd back-fllled
w1th the lnert ga~. Normal ~t~osphere i8 ~ufflclent to
stablllze the propoly~er durlng ~a~dlln~ and stora~e.
It ~ well-~nown that the eye len~ i8 layerod, llke
that of an onlon, wlth ~ch l~y-r h~vln~ a ~lff~rent re-
fractlve lndex. Th~ poly~erized co~posltlon ~8 ~8~0ntlal-
ly ho~o~en~ou~. ~owever, th~ viscoslty and rofractlv~
lndex o~ the co~positlon i8 a ~unction o~ th~ uncapped




. ~ ~ . . - .. . : . . .............................. . - -. ..
?

~:~` 6 1 330~51 : ~
1 portlon o~ ~he pr~poly~r, and aay b0 csn~gNr~d to pro~
vlde a refractive lndex b~tweon about l.S and 1.6.
Slnce the poly~erlzed composi~ion 24 18 ~n ~ to~er,
th~ ~uscles of the eye 10 ~ay otill p~rfor~ their nor~al
6 ~unction of acco~oda~ion. Further, the ~billty to tallor
the poly~-rlz~d oo~ool~ion ln tor~s Or Qlastici~y, vi~-
co~ity and refractlve lndex ~eans that the lons for~atlon,
when done ln co~Junction wlth the l~onication len~ r~oval,
~ay be perfor~ed ~arly ln the process of cataract for~a-
tlo~.

RXAMPL~S

Polyether ~lycols o~ avera~e ~ol~cular ~l~hts bc-
tween 1,000 and 4,000 were combined throu~h ur~thane llnk-
age~ u~ing dllsocyanates ~uch as lsophorone diisocyanate
(~luka Che~ical Corp., Hauppau~e, NY) or ~ethylene bis (4-
cyclohexyldilsocyanate) (Mobay Ch~tcal Corp., ~itt~bur~h,
PA). The ends were then capped wlth a co~pound contalnin~
a tor~lnal alke~e such as lsocyanatoethyl ~ethacrylate
(Dow Che~ical Co., Mldland, MI) or 2-hydroxyethyl sethac-
rylate (Aldrlch Che~lcal Co., Mllwaukee, WI). Reaction
were catalyzed by a tin co~pound ~uch as ~tannou~ dioctan~
oate.
The resultant pr~polymer ~as a colorless liguid with
vioco~ity ~u~ficie~tly low ~o that lt could be lnJected by
~yrin~e through a 20 gauge nsedle. The ~at~rl~l coul~ be
purified, if nocessary, throu~h various ~nown chro~ato-
~raphic ~thod~. BHT (25 to 100 pp~) ~y b~ added to
~tabillze the poly~er.
She ~oly~er was thorou~hly ~ixed with tb~ ~pproprl~t~
quantity o~ photolnltiator, ~uch ~ 2,2-dl~ethoxy-2 phenyl
acetoph~none ~Aldrlch Che~lcal Co.), tra~s~erred to
~yrln0~, then pumped in vacuo, pro~ct~d ~ro~ llght, gor


: ~, '~ ~. :'

. . -,

1 330q5 1 ::
1 at least 24 hrs. The polymer-filled syringc was ~tored,
protected f rom l~ght, under an lnert atmosphere.
The Table below liQt~ various polymer ~ormulations :
prepared pursuant to the foregoing teachlngs.
: 5
Table.

No. Polyether Dii~ocyanate Cata- End cap; Photoln-
alYcol ~ a linker: a l~st q itiator; X
; ~ 10
1 Voranol* IPDI 0.76 Sn(Oc)2 I~M; 0.29 DMPA; 0.3
(lg65); 8.8 .~
: 2 Voranol* IPDI; 0.96 -do- I~M; 0.28DMPA; 0.25 ::
(1965); 10.7
15 3 Voranol* IPDI; 0.58 -do- I~M; 0.~3 DMPA; 0.3
: (3829); 20.1
4 Voranol* IPDI; 1.1 -do- ~A; 0.69 DMPA; 1.2
(3829); 10.0 ~ :
: 5 PPG-4000~ De ~; 1.~ -do- H~M; 0.75 DMPA; 1.0
11.6
6 PPG-4000~ DeQW; 1.4 -do- HEA; 0.67 -do-
11.6
: 7 PPG-4000~ IPDI; 0.93 -do- HEA; 0.50 -do-
8.9 :~
25 8 PPG-3000;*~: IPDI 1.0 -do- ~EM; 0.31 -do~
9 . 0 ,-~
9 PPG-3000* IPDI; l.0 -do- HEA; 0.27 -do-
9,O ~ -
10 Terethane --- -do- I~M; 7.1 -do-
. 30 (650); 15.0

L~end~
;~ Voranol (1965) - Polypropylene ~lycol ¢nd capped with
; 12X ethylene oxlde; M~ = 1,965 ~ :

* - Trade-marks ~-
"~'~. ':,


` .~

_ 8 l 330951
,
1 Voranol ~3829) - Polypropylene ~lycol end capped with
22% ethylene oxlde; MW = 3,829
PPG-4000 - Polypropylene glycol; MW = ~,000
PPG-3000 - Polypropyl~ne glycol; MW = 3,000
Tcrethane (650) - Polytetramethylene ~lycol; MW = 650
IPDI - Ioophorono dllsocyanate
DesW - Desmodur*W tmethylene bis(4-cyclohexylisocyan-
ate)] .
Sn(Oc)2 - Stannous dloctanoate
IEM - I~ocyanatoethyl ~ethacrylate r' ~:
HEA - 2-Hydroxyethyl acrylate ;
HEM - 2-Hydroxyethyl methacrylate
DMPA - 2,2-Dimethoxy-2-phenylacetophenone
'
Several of the foregolng polymers (Nos. 1, 2, 5, 6,
~) were in~ected into len6 capsules of rabbit;s. Photo ;~
; cross-linking was promoted by the visible light used to
~; illuminate the surgical procedure. The poly~er was -
~; stabilized ln the lens shape within ~ to 2 ~inutes and
reaction wa~ complete withln 5 minutes.
The ~echanism for the photoinitiation apparently
lnvolves homolytic cleavage of the initiator to give two
radicals, which then lnltiate the cross-linking reaction.
Because molecular oxygen reacts with radlcals, deoxy~ena-
tlon of the ~onomer allow~ for rapid cross-linklng.
The re~ultant in situ cross-linked polymer was a
transparent plastlc with variable elasticity, depending on
the degree of cross-link~ng and chemlcal compositlon. ;
Thus, a ~ethod of endocapsular lens replacement by ~`
30 forming a synthetic polymer in the lens capsule of an eye -~
after removal of the len~ has been disclo~ed. The ~ethod
compri~es in~ecting a photosensitlve prepolymer into the --
lens capsule ln the absence of oxygen. It will be clear
to one of ordinary skill in the art that various changes
and modifications of an obvious nature ~ay be ~ade without
''''' " "'
. :
*- Trade-mark

,~ 9 1 330q51
. ;. ,
d~partln~ ~ro~ the splrlt o~ the lnv~ntlon, ~nd ~ uch
chan~os ~nd l~odl~lcation~ ~re con~lder-d to b~ ~ithln th~
~cop~ o~ the lnvontion, ~ de~inod by the~ ~ppend-d c:lal~.




: ~:, : .
~.


-

- -



' ... , .,: .
:~ ~ .' ,', ' '



: ""~
~ ' "' '~

Representative Drawing
A single figure which represents the drawing illustrating the invention.
Administrative Status

For a clearer understanding of the status of the application/patent presented on this page, the site Disclaimer , as well as the definitions for Patent , Administrative Status , Maintenance Fee  and Payment History  should be consulted.

Administrative Status

Title Date
Forecasted Issue Date 1994-07-26
(22) Filed 1988-06-28
(45) Issued 1994-07-26
Deemed Expired 2003-07-28

Abandonment History

There is no abandonment history.

Payment History

Fee Type Anniversary Year Due Date Amount Paid Paid Date
Application Fee $0.00 1988-06-28
Registration of a document - section 124 $0.00 1989-02-23
Maintenance Fee - Patent - Old Act 2 1996-07-26 $100.00 1996-07-19
Maintenance Fee - Patent - Old Act 3 1997-07-28 $100.00 1997-05-28
Maintenance Fee - Patent - Old Act 4 1998-07-27 $100.00 1998-06-30
Maintenance Fee - Patent - Old Act 5 1999-07-26 $150.00 1999-07-26
Maintenance Fee - Patent - Old Act 6 2000-07-26 $150.00 2000-07-26
Maintenance Fee - Patent - Old Act 7 2001-07-26 $75.00 2001-04-17
Owners on Record

Note: Records showing the ownership history in alphabetical order.

Current Owners on Record
CALIFORNIA INSTITUTE OF TECHNOLOGY
Past Owners on Record
COOTS, ROBERT J.
GRUBBS, ROBERT H.
PINE, STANLEY H.
Past Owners that do not appear in the "Owners on Record" listing will appear in other documentation within the application.
Documents

To view selected files, please enter reCAPTCHA code :



To view images, click a link in the Document Description column. To download the documents, select one or more checkboxes in the first column and then click the "Download Selected in PDF format (Zip Archive)" or the "Download Selected as Single PDF" button.

List of published and non-published patent-specific documents on the CPD .

If you have any difficulty accessing content, you can call the Client Service Centre at 1-866-997-1936 or send them an e-mail at CIPO Client Service Centre.


Document
Description 
Date
(yyyy-mm-dd) 
Number of pages   Size of Image (KB) 
Office Letter 1988-10-13 1 32
PCT Correspondence 1994-04-25 1 21
Prosecution Correspondence 1993-09-27 2 60
Examiner Requisition 1993-06-18 2 74
Prosecution Correspondence 1993-03-09 5 112
Examiner Requisition 1992-12-09 1 50
Prosecution Correspondence 1992-11-03 2 45
Examiner Requisition 1992-08-12 2 68
Prosecution Correspondence 1991-05-02 2 40
Examiner Requisition 1991-01-31 1 35
Description 1995-08-29 10 704
Drawings 1995-08-29 1 60
Claims 1995-08-29 5 488
Abstract 1995-08-29 1 60
Cover Page 1995-08-29 1 70
Representative Drawing 2000-08-04 1 7
Correspondence 2001-04-17 1 21
Fees 1996-07-19 1 55